Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516544 | SCV000615176 | uncertain significance | not specified | 2016-12-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448561 | SCV002612250 | uncertain significance | Inborn genetic diseases | 2019-10-31 | criteria provided, single submitter | clinical testing | The p.E1074G variant (also known as c.3221A>G), located in coding exon 8 of the SETX gene, results from an A to G substitution at nucleotide position 3221. The glutamic acid at codon 1074 is replaced by glycine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003233679 | SCV003931445 | uncertain significance | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233680 | SCV003931446 | uncertain significance | Amyotrophic lateral sclerosis type 4 | 2023-02-08 | criteria provided, single submitter | clinical testing |